Status:
TERMINATED
Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Diabetic Neuropathies
Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of DVS SR in the treatment of neuropathic pain associated with diabetic peripheral neuropathy.
Eligibility Criteria
Inclusion
- Diabetes type 1 or 2
- Painful symptoms of diabetic neuropathy in the lower extremities extremities for at least 6 months
Exclusion
- Major Depression
- Uncontrolled diabetes
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
408 Patients enrolled
Trial Details
Trial ID
NCT00283842
Start Date
March 1 2006
End Date
June 1 2008
Last Update
October 24 2011
Active Locations (51)
Enter a location and click search to find clinical trials sorted by distance.
1
Mesa, Arizona, United States, 85210
2
Peoria, Arizona, United States, 85381
3
Phoenix, Arizona, United States, 85016
4
Encino, California, United States, 91316